Product image of Ladinorm, (Bisoprolol Fumarate, Ramipril) supplied by GNH India

Ladinorm,

Active Ingredient:
Bisoprolol Fumarate, Ramipril
Origin:
EU

Ladinorm, (Bisoprolol Fumarate, Ramipril)

Bisoprolol Fumarate / Ramipril, the active ingredient in Ladinorm, is a beta‑blocker and ACE‑inhibitor combination presented as an oral tablet for systemic use. It is prescribed to manage high blood pressure, support heart failure therapy, and reduce risk after myocardial infarction, helping to lower blood pressure and improve cardiac function in affected patients.

GNH India supplies Ladinorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ladinorm, a combined beta‑blocker and ACE‑inhibitor, is used to treat cardiovascular conditions that involve elevated blood pressure and cardiac stress.

  • Hypertension: reduces systolic and diastolic pressure by decreasing heart rate and vascular resistance.
  • Heart failure: improves ventricular function and lowers cardiac workload.
  • Post‑myocardial infarction: lowers the risk of recurrent events by stabilising blood pressure and heart rate.

How It Works

  • Bisoprolol selectively blocks β1‑adrenergic receptors on cardiac myocytes, decreasing heart rate, contractility, and renin release. Ramipril inhibits angiotensin‑converting enzyme, preventing formation of angiotensin II and reducing aldosterone secretion, which together lower systemic vascular resistance and blood pressure, providing synergistic cardiovascular protection.

Side Effects

Ladinorm may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Dizziness: feeling light‑headed, especially on standing.
  • Fatigue: reduced energy levels during daily activities.
  • Headache: mild to moderate head pain.
  • Cough: dry, persistent throat irritation.
  • Hypotension: lower than normal blood pressure readings.
  • Bradycardia: slower than normal heart rate.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat.
  • Severe hypotension: marked drop in blood pressure causing fainting.
  • Bronchospasm: narrowing of airways, especially in asthmatic patients.
  • Hepatic dysfunction: abnormal liver enzyme elevations.
  • Renal impairment: reduced kidney function.
  • Allergic reactions: rash, itching, or anaphylaxis.

Precautions & Warnings

Before initiating Ladinorm, clinicians should assess patient-specific factors and monitor for potential complications.

  • Monitor blood pressure: check regularly to ensure therapeutic targets are met.
  • Assess renal function: adjust dosing if creatinine clearance is reduced.
  • Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension.
  • Use caution in asthma: β‑blockade may exacerbate bronchospasm.
  • Pregnancy and lactation: consult a physician as safety data are limited.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Ladinorm can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Concurrent ACE inhibitors or ARBs: may cause excessive blood pressure drop.
  • Non‑selective beta‑blockers with verapamil or diltiazem: risk of severe bradycardia.
  • Potassium‑rich supplements or potassium‑sparing diuretics: risk of hyperkalaemia.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may blunt antihypertensive response.
  • Diuretics: can increase risk of hypotension and electrolyte imbalance.

Frequently Asked Questions

Ladinorm is a fixed‑dose combination of bisoprolol fumarate and ramipril used to treat hypertension, chronic heart failure, and to reduce the risk of further cardiovascular events after a myocardial infarction. It works by lowering blood pressure and improving cardiac function.

Bisoprolol fumarate selectively blocks β1‑adrenergic receptors in the heart, decreasing heart rate, contractility, and renin release. This reduces cardiac workload and helps lower systemic blood pressure, contributing to overall cardiovascular protection.

The specific dose of Ladinorm is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments are made to achieve optimal blood pressure control and cardiac benefit.

Safety of Ladinorm in pregnancy and lactation has not been fully established. Physicians should evaluate the potential benefits against possible risks and consider alternative therapies if appropriate. Women who are pregnant or nursing should discuss treatment options with their healthcare provider.

To order Ladinorm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and required import documentation.

Ladinorm combines a beta‑blocker and an ACE inhibitor, offering dual mechanisms that can provide more consistent blood pressure control than a single‑agent therapy. Compared with monotherapy, the combination may reduce pill burden and improve adherence, but individual patient response and tolerance must be considered.

Ladinorm should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain potency and stability throughout its shelf life.

Ladinorm is taken orally, usually once daily with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe hypotension, bradycardia, angioedema, bronchospasm in asthmatic patients, and significant electrolyte disturbances such as hyperkalaemia. Patients should be monitored regularly for these events, especially during therapy initiation or dose changes.

Ladinorm is contraindicated in patients with known hypersensitivity to bisoprolol, ramipril, or any component of the formulation, as well as those with severe bradycardia, second‑ or third‑degree heart block, uncontrolled asthma, or a history of angioedema related to ACE‑inhibitor therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bisoprolol Fumarate, Ramipril

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT